Fortress Biotech (FBIO) Asset Utilization Ratio (2015 - 2026)

Fortress Biotech's Asset Utilization Ratio history runs 11 years deep, the most recent figure standing at 0.33 for Q4 2025.

• In Q4 2025, Asset Utilization Ratio fell 23.35% year-over-year to 0.33; the TTM figure through Dec 2025 stood at 0.33 (down 23.35% YoY), while the FY2025 annual figure was 0.37, changed 0.38% from the prior year.
• Asset Utilization Ratio for Q4 2025 stood at 0.33, down from 0.36 in the prior quarter.
• The five-year high for Asset Utilization Ratio was 0.43 in Q4 2024, with the low at 0.27 in Q3 2023.
• The 5-year median for Asset Utilization Ratio is 0.2 (2022), against an average of 0.17.
• The sharpest annual moves came in 2023 and 2024: Asset Utilization Ratio tumbled 220.06% in 2023, then jumped 280.27% in 2024.
• Fortress Biotech's Asset Utilization Ratio stood at 0.2 in 2021, then slumped by 163.04% to 0.12 in 2022, then jumped by 241.0% to 0.17 in 2023, then jumped by 143.51% to 0.43 in 2024, then declined by 23.35% to 0.33 in 2025.
• Business Quant data shows FBIO's Asset Utilization Ratio at 0.33 in Q4 2025, 0.36 in Q3 2025, and 0.34 in Q2 2025.